Independence and funding

Last updated 28 October 2026

The Commissure takes no money from drug companies or from makers of any treatment it covers. No company sees or pays for an article. There is no advertising.

Funding

Currently funded by the editor. Any future funding will be listed here.

The editor’s ties

Sofia Nychkalo has no financial ties to companies that make treatments for schizophrenia.

The Commissure newsletter

Monthly research updates.